Publications

  1. Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

GBD 2023 TB HIV Collaborators.Lancet Infect Dis. 2026 Jul 1:S1473-3099(26)00295-1. doi: 10.1016/S1473-3099(26)00295-1.

 

  1. Crowdsourcing technologies for out-of-hospital cardiac arrest response: A scoping review.

Mavrovounis G, Drivas K, Mermiri M, Papageorgiou K, Tsiotsikas O, Pantazopoulos I.Am J Emerg Med. 2026 Jun 16;109:43-51. doi: 10.1016/j.ajem.2026.06.017. Online ahead of print.PMID: 42364439 

 

  1. The effect of asymmetrical vs. symmetrical high flow nasal cannula on inspiratory effort.

Gerovasileiou E, Mavrovounis G, Menis AA, Karadimou K, Makris D, Pantazopoulos I.Crit Care. 2026 Jun 24;30(1):329. doi: 10.1186/s13054-026-06140-4.PMID: 42343410 Free PMC article. 

 

  1. Author Correction: Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a Global Burden of Disease Study.

Kang J, Kim HJ, Kim MS; GBD 2023 Substance Use Collaborators; Shin JI, Yon DK.Nat Med. 2026 Jul;32(7):2690. doi: 10.1038/s41591-026-04513-4.PMID: 42303780 

 

  1. Clinical Course and Perinatal Outcomes of Pregnant Women with COVID-19 in Central Greece: A Prospective Cohort Study.

Donoudis C, Garas A, Sotiriou S, Pantazopoulos I, Pagonis A, Zachari E, Daponte N, Syrogiannopoulos G, Grivea I, Daponte A.Diseases. 2026 May 19;14(5):178. doi: 10.3390/diseases14050178.PMID: 42187890 

 

  1. Reconsidering the Concept of High-Flow Nasal Cannula Weaning: The Role of Titration Rather Than Liberation.

Pantazopoulos I, Tatkov S.Chest. 2026 Apr;169(4):e146-e147. doi: 10.1016/j.chest.2025.10.045.PMID: 41963026 

 

  1. Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study.

GBD 2023 IHD & Dietary Risk Factors Collaborators.Nat Med. 2026 Apr;32(4):1454-1478. doi: 10.1038/s41591-026-04250-8. Epub 2026 Mar 30.

 

  1. Influence of Age in End-of-Life Practices in Worldwide ICUs (ETHICUS-2): A Prospective Observational Study.

Nagata I, Sprung CL, Lautrette A, Jaschinski U, Mullick S, Aggarwal A, Pantazopoulos I, Anstey MH, Jensen HI, Karlis G, Marliere MH, Tsagkaris I, Montiel BE, Barrachina LG, Weiss M, Romain M, Nunnally ME, Cerny V, Piras C, Miskolci O, Barth E, Ricou B, Avidan A; ETHICUS-2 Study Group.Crit Care Med. 2026 Apr 1;54(4):701-714. doi: 10.1097/CCM.0000000000007091. Epub 2026 Mar 16.PMID: 41860289

 

  1. Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021.

GBD 2021 AEMT Collaborators.Korean J Intern Med. 2026 Mar;41(2):350-366. doi: 10.3904/kjim.2025.278. Epub 2026 Mar 1.PMID: 41850226 

 

  1. High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial.

Crimi C, Sardo S, Noto A, Madotto F, Ippolito M, Nolasco S, Campisi R, Fiorentino G, Pantazopoulos I, Chalkias A, Mattei A, Scala R, Clini E, Ergan B, Lujan M, Winck JC, Giarratano A, Carlucci A, Gregoretti C, Groff P, Cortegiani A; COVID-HIGH Investigators.J Anesth Analg Crit Care. 2026 Feb 21;6(1):52. doi: 10.1186/s44158-026-00361-3.PMID: 41723547 

 

  1. Defining the bellwether procedures and processes for global trauma care: an international Delphi study.

Bath MF, Amoako J, Edmiston T, Ratnayake AS, Kabatoro D, Bagaria D, Menon R, Wohlgemut JM, Hobbs L, Smith BG, Nuño-Guzmán CM, Vélez SE, Brennan R, Conway Morris A, Hardcastle TC, Weiser T, Bashford T; Global Trauma Care Delphi Collaborative; Global Trauma Care Delphi.BMJ Glob Health. 2026 Feb 20;11(2):e020909. doi: 10.1136/bmjgh-2025-020909.PMID: 41720581 

 

  1. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a Global Burden of Disease Study.

Kang J, Kim HJ, Kim MS; GBD 2023 Substance Use Collaborators; Shin JI, Yon DK.Nat Med. 2026 Feb;32(2):527-544. doi: 10.1038/s41591-025-04137-0. Epub 2026 Jan 16.PMID: 41545593 

 

  1. Neuroprognostication After Cardiac Arrest Using Glial Fibrillary Acidic Protein: A Systematic Review and Meta-Analysis.

Mavrovounis G, Beltsios E, Boutsikos I, Tseriotis VS, Gkraikou T, Papageorgiou P, Mermiri M, Adamou A, Chatzis DG, Kalamatianos T, Pantazopoulos I.Crit Care Med. 2026 Apr 1;54(4):960-971. doi: 10.1097/CCM.0000000000007026. Epub 2026 Jan 15.

 

  1. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators.Lancet Infect Dis. 2026 Apr;26(4):343-361. doi: 10.1016/S1473-3099(25)00689-9. Epub 2025 Dec 15.PMID: 41412141

 

  1. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

GBD 2023 Intimate Partner Violence and Sexual Violence against Children Collaborators.Lancet. 2026 Jan 3;407(10523):31-52. doi: 10.1016/S0140-6736(25)02503-6. Epub 2025 Dec 9.PMID: 41386261 

 

  1. Mediterranean diet adherence and its association with inflammatory and oxidative stress biomarkers in asthma.

Kontopoulou L, Kotsiou OS, Tourlakopoulos K, Paraskevadaki E, Karpetas G, Malli F, Mavrovounis G, Pantazopoulos I, Daniil Z, Gourgoulianis KI.J Asthma. 2026 Mar;63(3):275-283. doi: 10.1080/02770903.2025.2592243. Epub 2025 Dec 15.PMID: 41383099

 

  1. Global, regional, and national burden of headache disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

GBD 2023 Headache Collaborators.Lancet Neurol. 2025 Dec;24(12):1005-1015. doi: 10.1016/S1474-4422(25)00402-8.PMID: 41240916 

 

  1. Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis.

GBD 2021 Global Sepsis Collaborators.Lancet Glob Health. 2025 Dec;13(12):e2013-e2026. doi: 10.1016/S2214-109X(25)00356-0. Epub 2025 Oct 21.PMID: 41135560

 

  1. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

GBD 2023 Causes of Death Collaborators.Lancet. 2025 Oct 18;406(10513):1811-1872. doi: 10.1016/S0140-6736(25)01917-8. Epub 2025 Oct 12.PMID: 41092928 

 

  1. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.

GBD 2023 Demographics Collaborators.Lancet. 2025 Oct 18;406(10513):1731-1810. doi: 10.1016/S0140-6736(25)01330-3. Epub 2025 Oct 12.PMID: 41092927 

 

  1. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

GBD 2023 Disease and Injury and Risk Factor Collaborators.Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12.PMID: 41092926 

 

  1. Persistent Respiratory Symptoms Post-COVID-19 in a Non-Hodgkin Lymphoma Patient: A Case Report.

Dimeas IE, Papra S, Dimeas G, Pantazopoulos I, Daniil Z.Cureus. 2025 Sep 9;17(9):e91885. doi: 10.7759/cureus.91885. eCollection 2025 Sep.PMID: 41080362 

 

  1. The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.

GBD 2023 Cancer Collaborators.Lancet. 2025 Oct 11;406(10512):1565-1586. doi: 10.1016/S0140-6736(25)01635-6. Epub 2025 Sep 24.PMID: 41015051 

 

  1. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.

Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators.J Am Coll Cardiol. 2025 Dec 2;86(22):2167-2243. doi: 10.1016/j.jacc.2025.08.015. Epub 2025 Sep 24.PMID: 40990886 

 

  1. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.

GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators; Rautalin I, Volovici V, Stark BA, Johnson CO, Kaprio J, Korja M, Krishnamurthi RV, Nair BS, Ranta A, Rinkel GJE, Vergouwen MDI, Abate YH, Abbastabar H, Abd-Allah F, Abdelkader A, Abdi P, Abdollahi A, Abdullahi A, Abiodun OO, Aboagye RG, Abouzid M, Abtahi D, Abu Rumeileh S, Abualhasan A, Abualruz H, Abukhadijah HJ, Abu-Zaid A, Adamu LH, Addo IY, Adedoyin RA, Adegboye OA, Adra S, Adzigbli LA, Agyemang-Duah W, Ahinkorah BO, Ahmad A, Ahmad D, Ahmadzade AM, Ahmed A, Ahmed H, Ahmed SA, Aji B, Al-Kaif MA, Al-Ajlouni Y, Al-Aly Z, Albashtawy M, Ali MU, Alif SM, Alimohamadi Y, Aljunid SM, Alomari MA, Alrawashdeh A, Alsabri MA, Salman RA, Altaf A, Al-Tammemi AB, Alvis-Guzman N, Alwafi H, Al-Wardat M, Al-Worafi YM, Aly H, Alyahya MSI, Alzoubi KH, Amani R, Amin TT, Amindarolzarbi A, Amusa GA, Anderlini D, Angappan D, Anil A, Anuoluwa BS, Anwar S, Anyasodor AE, Apostol GLC, Arabloo J, Areda D, Ärnlöv J, Artamonov AA, Artanti KD, Arumugam A, Aryan Z, Asghari-Jafarabadi M, Ashemo MY, Ashraf T, Athar M, Athari SS, Aujayeb A, Awotidebe AW, Azadnajafabad S, Aziz S, Azzam AY, Babu GR, Bagheri N, Bahrami Taghanaki P, Bahramian S, Bai …See abstract for full author list ➔JAMA Neurol. 2025 Aug 1;82(8):765-787. doi: 10.1001/jamaneurol.2025.1522.PMID: 40406922

 

  1. Unmasking Convergent Inflammatory and Oxidative Pathways in Asthma.

Tourlakopoulos K, Mavrovounis G, Kontopoulou L, Polyzois S, Pantazopoulos I, Kirgou P, Daniil Z, Gourgoulianis KI, Kotsiou OS.Allergy. 2025 Jun;80(6):1801-1806. doi: 10.1111/all.16575. Epub 2025 May 6.PMID: 40326823 

 

  1. Indirect Costs Arising From COVID-19-Related Work Absenteeism From October 2020 to July 2022: A Retrospective Study From Central Greece.

Lampropoulos IC, Rouka E, Pantazopoulos I, Aggelopoulos E, Papagiannis D, Malli F, Gourgoulianis KI.Cureus. 2025 Mar 28;17(3):e81358. doi: 10.7759/cureus.81358. eCollection 2025 Mar.PMID: 40291212

 

  1. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.

GBD 2021 Asthma and Allergic Diseases Collaborators.Lancet Respir Med. 2025 May;13(5):425-446. doi: 10.1016/S2213-2600(25)00003-7. Epub 2025 Mar 24.PMID: 40147466

 

  1. Global, regional, and national burden of household air pollution, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 HAP Collaborators.Lancet. 2025 Apr 5;405(10485):1167-1181. doi: 10.1016/S0140-6736(24)02840-X. Epub 2025 Mar 18.PMID: 40118081 

 

  1. Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD Epilepsy Collaborators.Lancet Public Health. 2025 Mar;10(3):e203-e227. doi: 10.1016/S2468-2667(24)00302-5. Epub 2025 Feb 24.PMID: 40015291 

 

  1. Pioneering Respiratory and Emergency Medicine Research During the COVID-19 Era.

Pantazopoulos I, Mavrovounis G, Gourgoulianis K.J Pers Med. 2025 Feb 18;15(2):73. doi: 10.3390/jpm15020073.PMID: 39997349 

 

  1. Stroke at the Hairdresser’s chair: A scoping review of the beauty parlor stroke syndrome.

Mavrovounis G, Drivas K, Syrakouli A, Syrakouli E, Mermiri M, Papanagiotou P, Pantazopoulos I.Am J Emerg Med. 2025 May;91:29-36. doi: 10.1016/j.ajem.2025.02.016. Epub 2025 Feb 15.PMID: 39987625

 

  1. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Suicide Collaborators.Lancet Public Health. 2025 Mar;10(3):e189-e202. doi: 10.1016/S2468-2667(25)00006-4. Epub 2025 Feb 19.PMID: 39986290

 

  1. Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021.

GBD 2021 Europe Life Expectancy Collaborators.Lancet Public Health. 2025 Mar;10(3):e172-e188. doi: 10.1016/S2468-2667(25)00009-X. Epub 2025 Feb 18.PMID: 39983748 

 

  1. The landscape of experimental cardiac arrest research models in rats: a bibliometric analysis of the 100 most cited articles.

Mavrovounis G, Mermiri M, Drivas I, Drivas K, Kalamatianos T, Zarogiannis SG, Pantazopoulos I.Clin Exp Emerg Med. 2025 Sep;12(3):198-211. doi: 10.15441/ceem.24.290. Epub 2025 Jan 14.PMID: 39807061 

 

  1. Acute Generalized Exanthematous Pustulosis Induced by Hyaluronic Acid Knee Injection: A Case Report.

Ntavari N, Mavrovounis G, Gravani A, Syrmou V, Roussaki AV, Zafiriou E, Pantazopoulos I.J Emerg Nurs. 2025 Jan;51(1):20-26. doi: 10.1016/j.jen.2024.08.005.PMID: 39800444

 

  1. Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial.

Monti G, Cabrini L, Kotani Y, Brusasco C, Kadralinova A, Giardina G, Chalkias A, Nakhnoukh C, Pantazopoulos I, Oliva FM, Dazzi F, Roasio A, Baiardo Redaelli M, Tripodi VF, Cucciolini G, Belletti A, Vaschetto R, Maj G, Borghi G, Savelli F, Boni S, D’Amico F, Cavallero S, Labanca R, Tresoldi M, Marmiere M, Marzaroli M, Moizo E, Monaco F, Nardelli P, Pieri M, Plumari V, Scandroglio AM, Turi S, Corradi F, Konkayev A, Landoni G, Bellomo R, Zangrillo A; NAVIGATE Study Group.Br J Anaesth. 2025 Feb;134(2):382-391. doi: 10.1016/j.bja.2024.11.023. Epub 2025 Jan 2.PMID: 39753402 

 

  1. Prevalence, Risk Factors, and Mortality of New-Onset Atrial Fibrillation in Mechanically Ventilated Critically Ill Patients.

Zakynthinos GE, Tsolaki V, Xanthopoulos A, Karavidas N, Vazgiourakis V, Bardaka F, Giamouzis G, Pantazopoulos I, Makris D.J Clin Med. 2024 Nov 9;13(22):6750. doi: 10.3390/jcm13226750.PMID: 39597893 

 

  1. Amikacin Liposomal Inhalation Suspension for Non-Tuberculous MycobacteriaLung Infection: A Greek Observational Study.

Loukeri AA, Papathanassiou E, Kavvada A, Kampolis CF, Pantazopoulos I, Moschos C, Papavasileiou A.Medicina (Kaunas). 2024 Oct 3;60(10):1620. doi: 10.3390/medicina60101620.PMID: 39459407 

 

  1. Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Pulmonary Arterial Hypertension Collaborators.Lancet Respir Med. 2024 Oct 18:S2213-2600(24)00295-9. doi: 10.1016/S2213-2600(24)00295-9. Online ahead of print.PMID: 39433052 

 

  1. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Tobacco Forecasting Collaborators.Lancet Public Health. 2024 Oct;9(10):e729-e744. doi: 10.1016/S2468-2667(24)00166-X.PMID: 39366729 

 

  1. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Stroke Risk Factor Collaborators.Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7.PMID: 39304265 

 

  1. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.

GBD 2021 Upper Respiratory Infections Otitis Media Collaborators.Lancet Infect Dis. 2024 Sep 9:S1473-3099(24)00430-4. doi: 10.1016/S1473-3099(24)00430-4. Online ahead of print.PMID: 39265593 

 

  1. Assessing the Impact of Spatial and Temporal Variability in Fine Particulate Matter Pollution on Respiratory Health Outcomes in Asthma and COPD Patients.

Xydi I, Saharidis G, Kalantzis G, Pantazopoulos I, Gourgoulianis KI, Kotsiou OS.J Pers Med. 2024 Aug 6;14(8):833. doi: 10.3390/jpm14080833.PMID: 39202024 Free PMC article.

 

  1. Nasal high flow or noninvasive ventilation? navigating hypercapnic COPD exacerbation treatment: A randomized noninferiority clinical trial.

Pantazopoulos I, Boutlas S, Mavrovounis G, Papalampidou A, Papagiannakis N, Kontou M, Bibaki E, Athanasiou N, Meletis G, Gourgoulianis K, Zakynthinos S, Ischaki E.Respir Med. 2024 Oct;232:107762. doi: 10.1016/j.rmed.2024.107762. Epub 2024 Aug 5.PMID: 39111544 Clinical Trial.

 

  1. Probing the efficacy of high-flow nasal cannula in the treatment of acute exacerbations of COPD with acute-moderate hypercapnic respiratory failure.

Pantazopoulos I, Mavrovouni G.Crit Care. 2024 Aug 5;28(1):264. doi: 10.1186/s13054-024-05050-7.PMID: 39103951 

 

  1. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050.

GBD 2019 MSK in Adolescents Collaborators. Electronic address: dongze_wu@163.com; GBD 2019 MSK in Adolescents Collaborators.Med. 2024 May 30:S2666-6340(24)00179-X. doi: 10.1016/j.medj.2024.04.009.

 

  1. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.

GBD 2021 Forecasting Collaborators.Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.

 

  1. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Risk Factors Collaborators.Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.

 

  1. Impact of Isolated Exercise-Induced Small Airway Dysfunction on Exercise Performance in Professional Male Cyclists.

Pigakis KM, Stavrou VT, Kontopodi AK, Pantazopoulos I, Daniil Z, Gourgoulianis K.Sports (Basel). 2024 Apr 19;12(4):112. doi: 10.3390/sports12040112.

 

  1. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.

GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators.Lancet Infect Dis. 2024 Apr 15:S1473-3099(24)00176-2. doi: 10.1016/S1473-3099(24)00176-2.

 

  1. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Causes of Death Collaborators.Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.

 

  1. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Fertility and Forecasting Collaborators.Lancet. 2024 Mar 19:S0140-6736(24)00550-6. doi: 10.1016/S0140-6736(24)00550-6.

 

  1. Evaluating the diagnostic and prognostic ability of ischemia modified albumin in COVID-19.

Pagonis A, Chalkias A, Mavrovounis G, Tourlakopoulos K, Marsitopoulos K, Papagiannakis N, Kechagia M, Makri E, Tsolaki V, Daniil Z, Gourgoulianis K, Pantazopoulos I. Heart Lung. 2024 Mar 22;66:16-22. doi: 10.1016/j.hrtlng.2024.03.003.

 

  1. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Nervous System Disorders Collaborators. Lancet Neurol. 2024 Apr;23(4):344-381. doi: 10.1016/S1474-4422(24)00038-3.

 

  1. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Demographics Collaborators. Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476-8.

 

  1. Sodium Glucose Co-Transporter 2 Inhibitors and the Cardiovascular System: Current Knowledge and Future Expectations.

Boutsikos I, Beltsios E, Schmack B, Pantazopoulos I, Chatzis DG. Heart Int. 2023 Dec 1;17(2):12-18. doi: 10.17925/HI.2023.17.2.12.

 

  1. Predicting the Outcome of Patients with Severe COVID-19 with Simple Inflammatory Biomarkers: The Utility of Novel Combined Scores-Results from a European Tertiary/Referral Centre.

Ntalouka MP, Brotis A, Mermiri M, Pagonis A, Chatzis A, Bareka M, Kotsi P, Pantazopoulos I, Gourgoulianis K, Arnaoutoglou EM. J Clin Med. 2024 Feb 8;13(4):967. doi: 10.3390/jcm13040967.

 

  1. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study.

Chalkias A, Huang Y, Ismail A, Pantazopoulos I, Papagiannakis N, Bitterman B, Anderson E, Catalan T, Erne GK, Tilley CR, Alaka A, Amadi KM, Presswalla F, Blakely P, Bernal-Morell E, Cebreiros López I, Eugen-Olsen J, García de Guadiana Romualdo L, Giamarellos-Bourboulis EJ, Loosen SH, Reiser J, Tacke F, Skoulakis A, Laou E, Banerjee M, Pop-Busui R, Hayek SS; International Study of Inflammation in COVID-19 (ISIC) Investigator Group.Crit Care Med. 2024 Feb 23. doi: 10.1097/CCM.0000000000006229.

 

 

  1. Multifocal Tuberculosis Verrucosa Cutis: Case Report and Review of the Literature.

Ntavari N, Syrmou V, Tourlakopoulos K, Malli F, Gerogianni I, Roussaki AV, Zafiriou E, Ioannou M, Tziastoudi E, Gourgoulianis KI, Pantazopoulos I.Medicina (Kaunas). 2023 Oct 2;59(10):1758. doi: 10.3390/medicina59101758.

 

  1. Physical Health-Related Quality of Life in Relation to Mediterranean Diet Adherence in a Sample of Greek Asthma Patients: A Pilot Study.

Kontopoulou L, Kotsiou OS, Tourlakopoulos K, Karpetas G, Paraskevadaki EV, Malli F, Pantazopoulos I, Daniil Z, Gourgoulianis KI.J Pers Med. 2023 Oct 20;13(10):1512. doi: 10.3390/jpm13101512.

 

  1. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019.

GBD 2019 IMID Collaborators.EClinicalMedicine. 2023 Sep 9;64:102193. doi: 10.1016/j.eclinm.2023.102193. eCollection 2023 Oct.

 

  1. Effects of Vasopressin Receptor Agonists during the Resuscitation of Hemorrhagic Shock: A Systematic Review and Meta-Analysis of Experimental and Clinical Studies.

Laou E, Papagiannakis N, Papadopoulou A, Choratta T, Sakellakis M, Ippolito M, Pantazopoulos I, Cortegiani A, Chalkias A.J Pers Med. 2023 Jul 16;13(7):1143. doi: 10.3390/jpm13071143.

 

  1. Evaluation of the Quality of Life of Patients with Myasthenia Gravis in Greece.

Aggelina A, Karampli E, Mavrovounis G, Boutsikos I, Pantazopoulos I, Kakavas S, Pavi E, Athanasakis K.J Pers Med. 2023 Jul 12;13(7):1130. doi: 10.3390/jpm13071130.

 

  1. A Hypertonic Seawater Nasal Irrigation Solution Containing Algal and Herbal Natural Ingredients Reduces Viral Load and SARS-CoV-2 Detection Time in the Nasal Cavity.

Pantazopoulos I, Chalkias A, Miziou A, Spanos M, Gerovasileiou E, Rouka E, Gourgoulianis K.J Pers Med. 2023 Jul 3;13(7):1093. doi: 10.3390/jpm13071093.

 

  1. From flatline to lifeline: A scoping review of the Lazarus phenomenon.

Mavrovounis G, Kontou M, Tsiotsikas O, Mermiri M, Tsolaki V, Beltsios E, Gourgoulianis K, Chalkias A, Pantazopoulos I.Am J Emerg Med. 2023 Oct;72:44-57. doi: 10.1016/j.ajem.2023.07.017. Epub 2023 Jul 17.

 

  1. D-ROMs and PAT Tests Reveal a High Level of Oxidative Stress in Patients with Severe Well-Controlled Asthma, and D-ROMs Are Positively Correlated with R20 Values That Indicate Approximate Central Airway Resistance.

Kotsiou OS, Tourlakopoulos K, Kontopoulou L, Mavrovounis G, Pantazopoulos I, Kirgou P, Zarogiannis SG, Daniil Z, Gourgoulianis KI.J Pers Med. 2023 Jun 2;13(6):943. doi: 10.3390/jpm13060943.

 

  1. Evaluation of Antibody Kinetics Following COVID-19 Vaccination in Greek SARS-CoV-2 Infected and Naïve Healthcare Workers.

Pavlidis G, Giannoulis V, Pirounaki M, Lampropoulos IC, Siafi E, Nitsa A, Pavlou E, Xanthaki A, Perlepe G, Fortis SP, Charalambous G, Kampolis CF, Pantazopoulos I.J Pers Med. 2023 May 29;13(6):910. doi: 10.3390/jpm13060910.

 

  1. Effect of Hydration on Pulmonary Function and Development of Exercise-Induced Bronchoconstriction among Professional Male Cyclists.

Pigakis KM, Stavrou VT, Pantazopoulos I, Daniil Z, Kontopodi-Pigaki AK, Gourgoulianis K.Adv Respir Med. 2023 Jun 7;91(3):239-253. doi: 10.3390/arm91030019.

 

  1. PEEP De-Escalation in Covid-19-induced Acute Respiratory Distress Syndrome Unloads the Right Ventricle Improving Hemodynamics and Oxygenation.

Tsolaki V, Zakynthinos GE, Papanikolaou J, Karavidas N, Vazgiourakis V, Papadonta ME, Zygoulis P, Pantazopoulos I, Makris D, Zakynthinos E. Am J Respir Crit Care Med. 2023 May 26. doi: 10.1164/rccm.202301-0154LE.

 

  1. Effects of Etomidate on Postintubation Hypotension, Inflammatory Markers, and Mortality in Critically Ill Patients with COVID-19: An International, Multicenter, Retrospective Study.

Leou K, Mendez D, Horani G, Papagiannakis N, Jiménez Sánchez R, Mazzei D, Mora I, Manickam R, Tourlakopoulos K, Garrido Peñalver JF, Jiménez Medina D, Rodríguez Mulero MD, Annousis K, Laou E, García de Guadiana-Romualdo L, Pantazopoulos I, Kaur K, Chalkias A; ETOCOVID Study group. J Intensive Care Med. 2023 May 7:8850666231173847. doi: 10.1177/08850666231173847.

 

  1. Current Management of Hypertension in Older Adults.

Chatzis DG, Magounaki K, Pantazopoulos I, Beltsios ET, Katsi V, Tsioufis KP. Drugs Aging. 2023 May;40(5):407-416. doi: 10.1007/s40266-023-01013-9.

 

  1. Investigation of admission serum creatinine as a predictor of hospital length of stay in triple-vaccinated COVID-19 inpatients.

Rouka E, Livanou E, Sinis S, Dimeas I, Pantazopoulos I, Papagiannis D, Malli F, Kotsiou O, Gourgoulianis KI. Int Health. 2023 Feb 15:ihad008. doi: 10.1093/inthealth/ihad008.

 

  1. Cutting-Edge Approaches in Respiratory and Critical Care Medicine.

Pantazopoulos I, Kotsiou OS. J Pers Med. 2023 Jan 3;13(1):105. doi: 10.3390/jpm13010105.

 

  1. Effect of PM2.5 Levels on ED Visits for Respiratory Causes in a Greek Semi-Urban Area.

Mermiri M, Mavrovounis G, Kanellopoulos N, Papageorgiou K, Spanos M, Kalantzis G, Saharidis G, Gourgoulianis K, Pantazopoulos I. J Pers Med. 2022 Nov 5;12(11):1849. doi: 10.3390/jpm12111849.

 

  1. Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma.

Kotsiou OS, Pantazopoulos I, Mavrovounis G, Marsitopoulos K, Tourlakopoulos K, Kirgou P, Daniil Z, Gourgoulianis KI. J Pers Med. 2022 Oct 28;12(11):1776. doi: 10.3390/jpm12111776.

 

  1. Safety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19.

Dimosiari A, Patoulias D, Pantazopoulos I, Zakynthinos E, Makris D. Eur J Intern Med. 2022 Nov 16:S0953-6205(22)00404-6. doi: 10.1016/j.ejim.2022.11.014.

 

  1. Contemporary Biomarkers in Pulmonary Embolism Diagnosis: Moving beyond D-Dimers.

Gkana A, Papadopoulou A, Mermiri M, Beltsios E, Chatzis D, Malli F, Adamou A, Gourgoulianis K, Mavrovounis G, Pantazopoulos I. J Pers Med. 2022 Sep 29;12(10):1604. doi: 10.3390/jpm12101604.

 

  1. Nasopharyngeal Wash with Normal Saline Decreases SARS-CoV-2 Viral Load: A Randomized Pilot Controlled Trial.

Pantazopoulos I, Chalkias A, Mavrovounis G, Dimeas I, Sinis S, Miziou A, Rouka E, Poulas K, Gourgoulianis K. Can Respir J. 2022 Sep 27;2022:8794127. doi: 10.1155/2022/8794127.

 

  1. COVID-19 and the cardiovascular system-current knowledge and future perspectives.

Chatzis DG, Magounaki K, Pantazopoulos I, Bhaskar SMM. World J Clin Cases. 2022 Sep 26;10(27):9602-9610. doi: 10.12998/wjcc.v10.i27.9602.

 

  1. Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.

De Pascale G, Antonelli M, Deschepper M, Arvaniti K, Blot K, Brown BC, de Lange D, De Waele J, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovetsky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, Blot S; Abdominal Sepsis Study (AbSeS) group and the Trials Group of the European Society of Intensive Care Medicine. Intensive Care Med. 2022 Nov;48(11):1593-1606. doi: 10.1007/s00134-022-06883-y.

 

  1. Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients.

Tsolaki V, Zakynthinos GE, Papadonta ME, Bardaka F, Fotakopoulos G, Pantazopoulos I, Makris D, Zakynthinos E. J Pers Med. 2022 Sep 19;12(9):1538. doi: 10.3390/jpm12091538.

 

  1. B-Cell Targeted Therapies in Patients with Multiple Sclerosis and Incidence of Headache: A Systematic Review and Meta-Analysis.

Mavridis T, Papagiannakis N, Breza M, Vavougios GD, Patas K, Daponte A, Laskaratos A, Archontakis-Barakakis P, Pantazopoulos I, Mitsikostas DD. J Pers Med. 2022 Sep 8;12(9):1474. doi: 10.3390/jpm12091474.

 

  1. The Use of Antenatal Dexamethasone in Late Preterm and Term Pregnancies to Improve Neonatal Morbidity and Mortality: A Systematic Review and Meta-Analysis.

Samouilidis A, Beltsios ET, Mavrovounis G, Adamou A, Belios I, Hadjivasilis A, Pantazopoulos I, Agouridis AP. Cureus. 2022 Aug 10;14(8):e27865. doi: 10.7759/cureus.27865

 

  1. Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis.

Pantazopoulos I, Mavrovounis G, Dimeas G, Zikos N, Pitsikou M, Rousogianni E, Mermiri M, Michou A, Spanos M, Maniotis C, Chalkias A, Laou E, Zakynthinos G, Chatzis D, Gourgoulianis K. Am J Cardiovasc Drugs. 2022 Aug 25:1-6. doi: 10.1007/s40256-022-00547-4.

 

  1. Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.

Luo S, Vasbinder A, Du-Fay-de-Lavallaz JM, Gomez JMD, Suboc T, Anderson E, Tekumulla A, Shadid H, Berlin H, Pan M, Azam TU, Khaleel I, Padalia K, Meloche C, O’Hayer P, Catalan T, Blakely P, Launius C, Amadi KM, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Altintas I, Eugen-Olsen J, Williams KA, Volgman AS, Reiser J, Hayek SS; ISIC (International Study of Inflammation in COVID‐19) Group. J Am Heart Assoc. 2022 Sep 20;11(18):e025198. doi: 10.1161/JAHA.122.025198.

 

  1. Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?

Pavlidis G, Kampolis CF, Perlepe G, Pagonis A, Maniotis C, Koullias E, Kranidioti H, Kyritsis A, Pavlou E, Sinis S, Pirounaki M, Vassilopoulos D, Gourgoulianis K, Pantazopoulos I. In Vivo. 2022 Jul-Aug;36(4):1944-1948. doi: 10.21873/invivo.12916.

 

  1. Physiologic effects of stress dose corticosteroids in in-hospital cardiac arrest (CORTICA): A randomized clinical trial.

Mentzelopoulos SD, Pappa E, Malachias S, Vrettou CS, Giannopoulos A, Karlis G, Adamos G, Pantazopoulos I, Megalou A, Louvaris Z, Karavana V, Aggelopoulos E, Agaliotis G, Papadaki M, Baladima A, Lasithiotaki I, Lagiou F, Temperikidis P, Louka A, Asimakos A, Kougias M, Makris D, Zakynthinos E, Xintara M, Papadonta ME, Koutsothymiou A, Zakynthinos SG, Ischaki E. Resusc Plus. 2022 May 26;10:100252. doi: 10.1016/j.resplu.2022.100252. eCollection 2022 Jun.

 

  1. Watch Out for Burnout in COVID-19: A Greek Health Care Personnel Study.

Mavrovounis G, Mavrovouni D, Mermiri M, Papadaki P, Chalkias A, Zarogiannis S, Christodoulou N, Gourgoulianis K, Pantazopoulos I. Inquiry. 2022 Jan-Dec;59:469580221097829. doi: 10.1177/00469580221097829.

 

  1. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial.

Crimi C, Noto A, Madotto F, Ippolito M, Nolasco S, Campisi R, De Vuono S, Fiorentino G, Pantazopoulos I, Chalkias A, Libra A, Mattei A, Scala R, Clini EM, Ergan B, Lujan M, Winck JC, Giarratano A, Carlucci A, Gregoretti C, Groff P, Cortegiani A; COVID-HIGH Investigators. Thorax. 2022 May 17:thoraxjnl-2022-218806. doi: 10.1136/thoraxjnl-2022-218806.

 

  1. Predictors of SARS-CoV-2 IgG Spike Antibody Responses on Admission and Clinical Outcomes of COVID-19 Disease in Fully Vaccinated Inpatients: The CoVax Study.

Livanou E, Rouka E, Sinis S, Dimeas I, Pantazopoulos I, Papagiannis D, Malli F, Kotsiou O, Gourgoulianis KI. J Pers Med. 2022 Apr 15;12(4):640. doi: 10.3390/jpm12040640.

 

  1. Circulating suPAR associates with severity and in-hospital progression of COVID-19.

Chalkias A, Skoulakis A, Papagiannakis N, Laou E, Tourlakopoulos K, Pagonis A, Michou A, Ntalarizou N, Mermiri M, Ragias D, Bernal-Morell E, Cebreiros López I, García de Guadiana-Romualdo L, Eugen-Olsen J, Gourgoulianis K, Pantazopoulos I; SPARCOL Investigators. Eur J Clin Invest. 2022 Apr 18:e13794. doi: 10.1111/eci.13794.

 

  1. Determinants of venous return in steady-state physiology and asphyxia-induced circulatory shock and arrest: an experimental study.

Chalkias A, Laou E, Papagiannakis N, Varvarousi G, Ragias D, Koutsovasilis A, Makris D, Varvarousis D, Iacovidou N, Pantazopoulos I, Xanthos T. Intensive Care Med Exp. 2022 Apr 12;10(1):13. doi: 10.1186/s40635-022-00440-z.

 

  1. Immune response to the severe acute respiratory syndrome coronavirus 2 vaccines: Is it sustained in the diabetes population?

Rouka E, Livanou E, Sinis S, Dimeas I, Pantazopoulos I, Papagiannis D, Malli F, Kotsiou O, Gourgoulianis KI.J Diabetes Investig. 2022 Mar 25. doi: 10.1111/jdi.13787.

 

  1. Therapeutic Vitamin D Supplementation Following COVID-19 Diagnosis: Where Do We Stand?-A Systematic Review.

Bania A, Pitsikakis K, Mavrovounis G, Mermiri M, Beltsios ET, Adamou A, Konstantaki V, Makris D, Tsolaki V, Gourgoulianis K, Pantazopoulos I.J Pers Med. 2022 Mar 8;12(3):419. doi: 10.3390/jpm12030419.

 

  1. Incorporating Biomarkers in COPD Management: The Research Keeps Going.

Pantazopoulos I, Magounaki K, Kotsiou O, Rouka E, Perlikos F, Kakavas S, Gourgoulianis K.J Pers Med. 2022 Mar 1;12(3):379. doi: 10.3390/jpm12030379.

 

  1. Medical/Surgical, Cloth and FFP/(K)N95 Masks: Unmasking Preference, SARS-CoV-2 Transmissibility and Respiratory Side Effects.

Mouliou DS, Pantazopoulos I, Gourgoulianis KI.J Pers Med. 2022 Feb 22;12(3):325. doi: 10.3390/jpm12030325.

 

  1. Hydropneumothorax With Persistent Air Leak in a Patient With Mild COVID-19 Disease.

Pantazopoulos IN, Pagonis A, Perlepe G, Kampolis CF, Gourgoulianis KI.Cureus. 2022 Feb 12;14(2):e22150. doi: 10.7759/cureus.22150. eCollection 2022 Feb.

 

  1. COVID-19 diagnosis in the emergency department: seeing the tree but losing the forest.

Mouliou DS, Pantazopoulos I, Gourgoulianis K.Emerg Med J. 2022 Mar 7:emermed-2021-212219. doi: 10.1136/emermed-2021-212219.

 

  1. COVID-19 Smart Diagnosis in the Emergency Department: all-in in Practice.

Mouliou DS, Pantazopoulos I, Gourgoulianis KI.Expert Rev Respir Med. 2022 Mar 10:1-10. doi: 10.1080/17476348.2022.2049760.

 

  1. Exercise-Induced Bronchospasm in Elite Athletes.

Pigakis KM, Stavrou VT, Pantazopoulos I, Daniil Z, Kontopodi AK, Gourgoulianis K.Cureus. 2022 Jan 3;14(1):e20898. doi: 10.7759/cureus.20898.

 

  1. Social Response to the Vaccine against COVID-19: The Underrated Power of Influence.

Mouliou DS, Pantazopoulos I, Gourgoulianis KI.J Pers Med. 2021 Dec 29;12(1):15. doi: 10.3390/jpm12010015.

 

  1. Alanine aminotransferase serum levels in COVID-19 patients inversely correlate with SARS-CoV-2 antigen.

Rouka E, Kotsiou OS, Perlepe G, Pagonis A, Pantazopoulos I, Gourgoulianis KI.Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e1080. doi: 10.1097/MEG.0000000000002105.

 

  1. Early corticosteroid initiation delays viral RNA clearance in respiratory secretions of COVID-19 patients.

Pantazopoulos I, Mavrovounis G, Kyritsis A, Perlepe G, Miziou A, Gourgoulianis K.Adv Respir Med. 2021;89(6):624-625. doi: 10.5603/ARM.a2021.0112.

 

  1. Comparison of advanced closed-loop ventilation modes with pressure support ventilation for weaning from mechanical ventilation in adults: A systematic review and meta-analysis.

Kampolis CF, Mermiri M, Mavrovounis G, Koutsoukou A, Loukeri AA, Pantazopoulos I.J Crit Care. 2021 Nov 25;68:1-9. doi: 10.1016/j.jcrc.2021.11.010.

 

  1. Sublingual microcirculatory alterations during the immediate and early postoperative period: A systematic review and meta-analysis.

Chalkias A, Papagiannakis N, Mavrovounis G, Kolonia K, Mermiri M, Pantazopoulos I, Laou E, Arnaoutoglou E.Clin Hemorheol Microcirc. 2021 Oct 26. doi: 10.3233/CH-211214.

 

  1. Management of COVID-19 Patients in the Emergency Department.

Pantazopoulos I, Tsikrika S, Kolokytha S, Manos E, Porpodis K.J Pers Med. 2021 Sep 27;11(10):961. doi: 10.3390/jpm11100961.

 

  1. Societal Criticism towards COVID-19: Assessing the Theory of Self-Diagnosis Contrasted to Medical Diagnosis.

Mouliou DS, Pantazopoulos I, Gourgoulianis KI.Diagnostics (Basel). 2021 Sep 27;11(10):1777. doi: 10.3390/diagnostics11101777.

 

  1. Temporal Associations of the SARS-CoV-2 NP Antigen and Anti-Spike Total Ig Levels with Laboratory Parameters in a Greek Cohort of Hospitalized COVID-19 Patients.

Rouka E, Kotsiou OS, Perlepe G, Pagonis A, Pantazopoulos I, Gourgoulianis KI.Can Respir J. 2021 Sep 20;2021:6590528. doi: 10.1155/2021/6590528.

 

  1. Intentional ingestion of batteries and razor blades by a prisoner: a true emergency?

Pantazopoulos I, Mavrovounis G, Mermiri M, Adamou A, Gourgoulianis K.Int J Prison Health. 2021 Sep 23;ahead-of-print(ahead-of-print). doi: 10.1108/IJPH-06-2021-0054.

 

  1. “Blow with the high flow” an updated algorithm.

Ischaki E, Pantazopoulos I. Journal of Emergency and Critical Care Medicine [Internet]. 2019 Dec 13;3(0).

 

  1. Nasal high flow application for perioperative support of respiratory system in adult patients.

Pantazopoulos I, Adamos G, Sotiriou A, Chalkias A, Gourgoulianis K, Zakynthinos S, et al. Journal of Emergency and Critical Care Medicine [Internet]. 2020 Apr 10;4(0).

 

  1. Stress hormones kinetics in ventricular fibrillation cardiac arrest and resuscitation: Translational and therapeutic implications.

Pantazopoulos I, Boutsikos I, Mavrovounis G, Graikou T, Faa G, Barouxis D, Kesidou E, Mavridis T, Chalkias A, Xanthos T.Am J Emerg Med. 2021 Jul 9;50:14-21. doi: 10.1016/j.ajem.2021.07.016.

 

  1. Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.

Chalkias A, Pantazopoulos I, Papagiannakis N, Skoulakis A, Laou E, Kolonia K, Ntalarizou N, Tourlakopoulos K, Pagonis A, Kampolis C, De Guadiana Romualdo LG, Ragias D, Eugen-Olsen J, Gourgoulianis K, Arnaoutoglou E; SPARCOL Investigators.Toxicol Rep. 2021;8:1394-1398. doi: 10.1016/j.toxrep.2021.07.004.

 

  1. Baseline Values and Kinetics of IL-6, Procalcitonin, and TNF-αin Landrace-Large White Swine Anesthetized with Propofol-Based Total Intravenous Anesthesia.

Chalkias A, Spyropoulos V, Georgiou G, Laou E, Koutsovasilis A, Pantazopoulos I, Kolonia K, Vrakas S, Papalois A, Demeridou S, Gourgoulianis K, Dontas I, Kaparos G, Baka S, Xanthos T.Biomed Res Int. 2021 Jun 19;2021:6672573. doi: 10.1155/2021/6672573.

 

  1. Effect of PM2.5Levels on Respiratory Pediatric ED Visits in a Semi-Urban Greek Peninsula.

Kanellopoulos N, Pantazopoulos I, Mermiri M, Mavrovounis G, Kalantzis G, Saharidis G, Gourgoulianis K.Int J Environ Res Public Health. 2021 Jun 12;18(12):6384. doi: 10.3390/ijerph18126384

 

 

  1. Driving Pressure in COVID-19 ARDS is Associated with Respiratory Distress Duration Before Intubation.

Tsolaki VS, Zakynthinos GE, Mantzarlis KD, Deskata KV, Papadonta ME, Gerovasileiou ES, Manoulakas EE, Zakynthinos E, Pantazopoulos IN, Makris DA.Am J Respir Crit Care Med. 2021 Jun 15. doi: 10.1164/rccm.202101-0234LE.

 

  1. Proportional assist ventilation versus pressure support ventilation for weaning from mechanical ventilation in adults: weaning success and mortality.

Pantazopoulos I, Mavrovounis G, Mermiri M, Kampolis C.Crit Care. 2021 Jun 10;25(1):200. doi: 10.1186/s13054-021-03575-9.

 

  1. Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Vogelaers D, Blot S, Van den Berge A, Montravers P; Abdominal Sepsis Study (‘AbSeS’) Group on behalf of the Trials Group of the European Society of Intensive Care Medicine.Drugs. 2021 Jun;81(9):1065-1078. doi: 10.1007/s40265-021-01534-w.

 

  1. Pulmonary function testing in COPD: looking beyond the curtain of FEV1.

Kakavas S, Kotsiou OS, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K, Pantazopoulos I.NPJ Prim Care Respir Med. 2021 May 7;31(1):23. doi: 10.1038/s41533-021-00236-w.

 

  1. Continuous chest compressions with asynchronous ventilation improve survival in a neonatal swine model of asphyxial cardiac arrest.

Aggelina A, Pantazopoulos I, Giokas G, Chalkias A, Mavrovounis G, Papalois A, Douvanas A, Xanthos T, Iacovidou N.Am J Emerg Med. 2021 Apr 5;48:60-66. doi: 10.1016/j.ajem.2021.04.009.

 

  1. Video Laryngoscopy Improves Intubation Times With Level C Personal Protective Equipment in Novice Physicians: A Randomized Cross-Over Manikin Study.

Pantazopoulos I, Kolonia K, Laou E, Mermiri M, Tsolaki V, Koutsovasilis A, Zakynthinos G, Gourgoulianis K, Arnaoutoglou E, Chalkias A.J Emerg Med. 2021 Jun;60(6):764-771. doi: 10.1016/j.jemermed.2021.01.001. Epub 2021 Feb 9.

 

  1. Repeated Antigen-Based Rapid Diagnostic Testing for Estimating the Coronavirus Disease 2019 Prevalence from the Perspective of the Workers’ Vulnerability before and during the Lockdown.

Kotsiou OS, Pantazopoulos I, Papagiannis D, Fradelos EC, Kanellopoulos N, Siachpazidou D, Kirgou P, Mouliou DS, Kyritsis A, Kalantzis G, Saharidis GKD, Tzounis E, Gourgoulianis KI.Int J Environ Res Public Health. 2021 Feb 9;18(4):1638. doi: 10.3390/ijerph18041638.

 

  1. A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients With COVID-19.

Chalkias A, Barreto EF, Laou E, Kolonia K, Scheetz MH, Gourgoulianis K, Pantazopoulos I, Xanthos T.Clin Ther. 2021 Mar;43(3):e57-e70. doi: 10.1016/j.clinthera.2021.01.004.

 

  1. Critical emergency medicine and the resuscitative care unit.

Mermiri M, Mavrovounis G, Chatzis D, Mpoutsikos I, Tsaroucha A, Dova M, Angelopoulou Z, Ragias D, Chalkias A, Pantazopoulos I.Acute Crit Care. 2021 Feb;36(1):22-28. doi: 10.4266/acc.2020.00521.

 

  1. Nasal high-flow oxygen versusnoninvasive ventilation in acute exacerbation of COPD: protocol for a randomised noninferiority clinical trial.

Papalampidou A, Bibaki E, Boutlas S, Pantazopoulos I, Athanasiou N, Moylan M, Vlachakos V, Grigoropoulos V, Eleftheriou K, Daniil Z, Gourgoulianis K, Kalomenidis I, Zakynthinos S, Ischaki E.ERJ Open Res. 2020 Oct 19;6(4):00114-2020. doi: 10.1183/23120541.00114-2020.

 

  1. Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.

Azam TU, Shadid HR, Blakely P, O’Hayer P, Berlin H, Pan M, Zhao P, Zhao L, Pennathur S, Pop-Busui R, Altintas I, Tingleff J, Stauning MA, Andersen O, Adami ME, Solomonidi N, Tsilika M, Tober-Lau P, Arnaoutoglou E, Keitel V, Tacke F, Chalkias A, Loosen SH, Giamarellos-Bourboulis EJ, Eugen-Olsen J, Reiser J, Hayek SS; International Study of Inflammation in COVID-19.J Am Soc Nephrol. 2020 Nov;31(11):2725-2735. doi: 10.1681/ASN.2020060829.

 

  1. Drones for Automated External Defibrillator Delivery: Where Do We Stand?

Mermiri MI, Mavrovounis GA, Pantazopoulos IN.J Emerg Med. 2020 Nov;59(5):660-667. doi: 10.1016/j.jemermed.2020.07.027.

 

  1. Peripherally Inserted Central Catheter lines for Intensive Care Unit and onco-hematologic patients: A systematic review and meta-analysis.

Mavrovounis G, Mermiri M, Chatzis DG, Pantazopoulos I.Heart Lung. 2020 Nov-Dec;49(6):922-933. doi: 10.1016/j.hrtlng.2020.07.008.

 

  1. Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients.

Chalkias A, Mouzarou A, Samara E, Xanthos T, Ischaki E, Pantazopoulos I.Mol Diagn Ther. 2020 Oct;24(5):517-521. doi: 10.1007/s40291-020-00481-8.

 

  1. COVID-19 pandemic and cardiovascular disease: where do we stand?

Chatzis DG, Magounaki KT, Pantazopoulos IN, Johnson EO, Tsioufis KP.Minerva Cardioangiol. 2020 Aug;68(4):347-358. doi: 10.23736/S0026-4725.20.05298-6.

 

  1. Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group.

Velissaris D, Dimopoulos G, Parissis J, Alexiou Z, Antonakos N, Babalis D, Gerakari S, Kaldis V, Koutoukas P, Lada M, Leventogiannis K, Pantazopoulos I, Papadopoulos A, Polyzogopoulou E, Gogos C, Armaganidis A, Giamarellos-Bourboulis EJ.Infect Dis Ther. 2020 Sep;9(3):407-416. doi: 10.1007/s40121-020-00301-w.

 

  1. Should Istay or should Igo? Pulmonary embolism and air travel.

Pantazopoulos I, Gourgoulianis K.Adv Respir Med. 2019;87(6):277. doi: 10.5603/ARM.2019.0070.

 

  1. Nasal High Flow Use in COPD Patients with Hypercapnic Respiratory Failure: Treatment Algorithm & Review of the Literature.

Pantazopoulos I, Daniil Z, Moylan M, Gourgoulianis K, Chalkias A, Zakynthinos S, Ischaki E.COPD. 2020 Feb;17(1):101-111. doi: 10.1080/15412555.2020.1715361.

 

  1. A “chain” in the right main bronchus?

Pantazopoulos I, Mermiri M, Gourgoulianis K. Visual Journal of Emergency Medicine. 2021 Jan 1;22:100957

 

  1. Challenges in procedural sedation and analgesia in the emergency department.

Raffay V, Fišer Z, Samara E, Magounaki K, Chatzis D, Mavrovounis G, Mermiri M, Žunić F, Pantazopoulos I. Journal of Emergency and Critical Care Medicine [Internet]. 2020 Jul 30;4(0)